Data and R code accompanying the manuscript "The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia"

Pavelka, Martin; Zandvoort, Kevin van; Abbott, Sam; Sherratt, Katharine; Majdán, Marek; Jarčuška, Pavol; Krajčí, Marek; Funk, Sebastian

doi:10.5281/zenodo.4570939

2021

DOI: 10.5281/zenodo.4570939

|View full text |Cite

Data and R code accompanying the manuscript "The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia"

Martin Pavelka¹,

Kevin van Zandvoort²,

Sam Abbott³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data and materials availability: Daily incidence of positive COVID-19 test reports and the results of the mass testing are available through governmental websites(12,20). All analyses were conducted in R (21) and can be found at(22). This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.…”

mentioning

confidence: 99%

The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia

Pavelka

Zandvoort

Abbott

et al. 2021

Science

Self Cite

165

210

View full text Add to dashboard Cite

Slovakia conducted multiple rounds of population-wide rapid antigen testing for SARS-CoV-2 in late 2020, combined with a period of additional contact restrictions. Observed prevalence decreased by 58% (95% CI: 57-58%) within one week in the 45 counties that were subject to two rounds of mass testing, an estimate that remained robust when adjusting for multiple potential confounders. Adjusting for epidemic growth of 4.4% (1.1-6.9%) per day preceding the mass testing campaign, the estimated decrease in prevalence compared to a scenario of unmitigated growth was 70% (67-73%). Modelling indicated that this decrease could not be explained solely by infection control measures, but required the additional impact of isolation and quarantine of household members of those testing positive.

show abstract

mentioning

confidence: 99%

The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia

Pavelka

Zandvoort

Abbott

et al. 2021

Science

Self Cite

165

210

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Data and R code accompanying the manuscript "The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia"

Cited by 1 publication

References 0 publications

The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia

The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia

Contact Info

Product

Resources

About